Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)
Close on Nov 17, 2026Market cap $3.31BP/E –Yield –
Axogen cash
Cash and short-term investments held at the end of each period.
Axogen's cash was $348.07M at Sep 30, 2026. For fiscal 2025 it was $41.53M, up 5.2% from the year before. Over ten years it grew 4.8% a year on average. The highest annual figure on record is $122.61M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.53M | +5.2% |
| FY2024 | Dec 31, 2024 | $39.48M | +6.6% |
| FY2023 | Dec 31, 2023 | $37.03M | -32.7% |
| FY2022 | Dec 31, 2022 | $55.04M | -39.1% |
| FY2021 | Dec 31, 2021 | $90.34M | -18.5% |
| FY2020 | Dec 31, 2020 | $110.81M | +8.1% |
| FY2019 | Dec 31, 2019 | $102.51M | -16.4% |
| FY2018 | Dec 31, 2018 | $122.61M | +235.8% |
| FY2017 | Dec 31, 2017 | $36.51M | +21.6% |
| FY2016 | Dec 31, 2016 | $30.02M | +15.8% |
| FY2015 | Dec 31, 2015 | $25.91M | +215.4% |
| FY2014 | Dec 31, 2014 | $8.22M | -59.1% |
| FY2013 | Dec 31, 2013 | $20.07M | +44.3% |
| FY2012 | Dec 31, 2012 | $13.91M | +69.8% |
| FY2011 | Dec 31, 2011 | $8.19M | +355.3% |
| FY2010 | Dec 31, 2010 | $1.80M | +536.2% |
| FY2009 | Dec 31, 2009 | $282.80K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $348.07M | +774.7% |
| Q2 FY2026 | Jun 30, 2026 | $111.41M | +210.1% |
| Q1 FY2026 | Mar 31, 2026 | $101.60M | +262.0% |
| Q4 FY2025 | Dec 31, 2025 | $41.53M | +5.2% |
| Q3 FY2025 | Sep 30, 2025 | $39.79M | +30.3% |
| Q2 FY2025 | Jun 30, 2025 | $35.92M | +32.4% |
| Q1 FY2025 | Mar 31, 2025 | $28.07M | +18.8% |
| Q4 FY2024 | Dec 31, 2024 | $39.48M | +6.6% |
| Q3 FY2024 | Sep 30, 2024 | $30.53M | -20.9% |
| Q2 FY2024 | Jun 30, 2024 | $27.13M | -33.5% |
| Q1 FY2024 | Mar 31, 2024 | $23.63M | -46.4% |
| Q4 FY2023 | Dec 31, 2023 | $37.03M | -32.7% |
| Q3 FY2023 | Sep 30, 2023 | $38.59M | -35.0% |
| Q2 FY2023 | Jun 30, 2023 | $40.78M | -36.6% |
| Q1 FY2023 | Mar 31, 2023 | $44.12M | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $55.04M | -39.1% |
| Q3 FY2022 | Sep 30, 2022 | $59.36M | -39.5% |
| Q2 FY2022 | Jun 30, 2022 | $64.28M | -39.5% |
| Q1 FY2022 | Mar 31, 2022 | $73.67M | -24.2% |
| Q4 FY2021 | Dec 31, 2021 | $90.34M | -18.5% |
| Q3 FY2021 | Sep 30, 2021 | $98.05M | -8.1% |
| Q2 FY2021 | Jun 30, 2021 | $106.25M | -3.4% |
| Q1 FY2021 | Mar 31, 2021 | $97.24M | +9.2% |
| Q4 FY2020 | Dec 31, 2020 | $110.81M | +8.1% |
| Q3 FY2020 | Sep 30, 2020 | $106.74M | +0.6% |
| Q2 FY2020 | Jun 30, 2020 | $109.94M | +0.8% |
| Q1 FY2020 | Mar 31, 2020 | $89.04M | -21.8% |
| Q4 FY2019 | Dec 31, 2019 | $102.51M | -16.4% |
| Q3 FY2019 | Sep 30, 2019 | $106.07M | -16.1% |
| Q2 FY2019 | Jun 30, 2019 | $109.06M | -18.3% |
| Q1 FY2019 | Mar 31, 2019 | $113.85M | +272.5% |
| Q4 FY2018 | Dec 31, 2018 | $122.61M | +235.8% |
| Q3 FY2018 | Sep 30, 2018 | $126.37M | +473.3% |
| Q2 FY2018 | Jun 30, 2018 | $133.56M | +459.5% |
| Q1 FY2018 | Mar 31, 2018 | $30.56M | +17.9% |
| Q4 FY2017 | Dec 31, 2017 | $36.51M | +21.6% |
| Q3 FY2017 | Sep 30, 2017 | $22.04M | – |
| Q2 FY2017 | Jun 30, 2017 | $23.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $25.91M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.02M | – |
See a number that looks wrong?